Literature DB >> 12445864

A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro.

Anne-Marie Lambeir1, Paul Proost, Simon Scharpé, Ingrid De Meester.   

Abstract

In vivo inactivation of glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) was found to be associated with the proteolytic removal of their N-terminal dipeptide by the ectopeptidase dipeptidyl peptidase IV (DPP IV). Previous studies suggested that the in vivo metabolism of GLP-1 is much faster than that of GLP-2. In this paper, we investigated the in vitro truncation of GLP-2 and GLP-1 by DPP IV. The slower conversion rate observed for GLP-2 compared to GLP-1 was due to an approximately 10-fold reduction in catalytic rate constant. The selectivity of DPP IV for the glucagon-like peptides was compared with data obtained for other natural substrates using the same enzyme source in identical conditions. Copyright 2002 Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445864     DOI: 10.1016/s0006-2952(02)01415-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Extending residence time and stability of peptides by protected graft copolymer (PGC) excipient: GLP-1 example.

Authors:  Gerardo M Castillo; Sandra Reichstetter; Elijah M Bolotin
Journal:  Pharm Res       Date:  2011-08-04       Impact factor: 4.200

Review 2.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

3.  Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs.

Authors:  L Simonsen; J J Holst; C F Deacon
Journal:  Diabetologia       Date:  2006-01-31       Impact factor: 10.122

4.  Influence of selective fluorination on the biological activity and proteolytic stability of glucagon-like peptide-1.

Authors:  He Meng; Subrahmanian Tarakkad Krishnaji; Martin Beinborn; Krishna Kumar
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

5.  Induced-fit mechanism for prolyl endopeptidase.

Authors:  Min Li; Changqing Chen; David R Davies; Thang K Chiu
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

6.  Monitoring of the effects of transfection with baculovirus on Sf9 cell line and expression of human dipeptidyl peptidase IV.

Authors:  Ozlem Ustün-Aytekin; Ismet Deliloğlu Gürhan; Kayoko Ohura; Teruko Imai; Gaye Ongen
Journal:  Cytotechnology       Date:  2013-05-29       Impact factor: 2.058

7.  Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation.

Authors:  Kathleen Aertgeerts; Sheng Ye; Mike G Tennant; Michelle L Kraus; Joe Rogers; Bi-Ching Sang; Robert J Skene; David R Webb; G Sridhar Prasad
Journal:  Protein Sci       Date:  2004-01-10       Impact factor: 6.725

8.  Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior.

Authors:  Ernest Y Tan; Michelle Mujoomdar; Jonathan Blay
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

9.  GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states.

Authors:  Gustavo J Hein; Chris Baker; Joanne Hsieh; Sarah Farr; Khosrow Adeli
Journal:  Diabetes       Date:  2012-10-01       Impact factor: 9.461

10.  Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.

Authors:  Nicole E B Skinner; Matthew S Wroblewski; Julie A Kirihara; Gary L Nelsestuen; Elizabeth R Seaquist
Journal:  Diabetes Ther       Date:  2015-07-22       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.